HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects (Q43260384)

17 November 2017

HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects (English)

1 reference

17 November 2017

0 references

Gianna Ferretti

1

1 reference

17 November 2017

Tiziana Bacchetti

series ordinal

2

1 reference

17 November 2017

Simona Masciangelo

series ordinal

3

1 reference

17 November 2017

Virginia Bicchiega

series ordinal

4

1 reference

17 November 2017

15 October 2009

1 reference

17 November 2017

1 reference

17 November 2017

18

1 reference

17 November 2017

6

1 reference

17 November 2017

1079-1084

1 reference

The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat.

17 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Mechanisms of disease: proatherogenic HDL--an evolving field

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

On the ability of high density lipoproteins to remove phospholipid peroxidation products from erythrocyte membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Adipose tissue dysfunction in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Inflammation, obesity, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Structural modifications of HDL and functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Estrogen esters as substrates for human paraoxonases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Modulation of paraoxonase (PON1) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Antioxidant vitamin levels in plasma and low density lipoprotein of obese girls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Copper-induced oxidative damage on astrocytes: protective effect exerted by human high density lipoproteins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

The relationships of leptin, adiponectin levels and paraoxonase activity with metabolic and cardiovascular risk factors in females treated with psychiatric drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Relationship of adiponectin to serum paraoxonase 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Modulation of membrane composition of swine vascular smooth muscle cells by homologous lipoproteins in culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.338

31 March 2020

Identifiers

DOI

10.1038/OBY.2009.338

1 reference

17 November 2017

1 reference